Page 8 - Genesis Medtech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SINGAPORE, May 25, 2021 - ( JCN Newswire ) - Genesis MedTech Group ( Genesis ), a leading medical device company, today announced it has completed its Series B round, raising significant growth financing. General Atlantic, a leading global growth equity firm, led the funding with participation from CITIC Capital and others. The majority of shareholders from Series A followed up with additional investments. Lefei Sun, Managing Director and Head of Healthcare for China at General Atlantic, will join the Genesis Board of Directors. The funds will be used to drive the research and development of new products and the commercialization of existing products, as well as enable business expansion in emerging markets around the world. This acceleration in Genesis model is expected to enable patients and healthcare practitioners in emerging markets to access innovative medtech products that can address unmet needs faced day-to-day Genesis mission since its inception in 2019.

Sao pauloNew yorkUnited statesScience parkSingapore generalPalo altoHong kongMexico cityDistrito federalCity ofUnited kingdomJakarta rayaNoord hollandKaren chngWarren wangTracy huang